Quinn Opportunity Partners LLC Takes $6.58 Million Position in Ventas, Inc. $VTR

Quinn Opportunity Partners LLC purchased a new position in shares of Ventas, Inc. (NYSE:VTRFree Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 94,000 shares of the real estate investment trust’s stock, valued at approximately $6,579,000.

A number of other hedge funds have also bought and sold shares of the company. Norges Bank bought a new stake in Ventas in the second quarter valued at about $344,740,000. Vanguard Group Inc. lifted its holdings in Ventas by 4.1% during the 2nd quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock worth $4,533,937,000 after buying an additional 2,854,751 shares during the last quarter. UBS Group AG lifted its holdings in Ventas by 142.4% during the 3rd quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock worth $245,514,000 after buying an additional 2,060,770 shares during the last quarter. Citigroup Inc. grew its position in shares of Ventas by 451.9% in the 2nd quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock worth $146,277,000 after acquiring an additional 1,896,627 shares in the last quarter. Finally, Lasalle Investment Management Securities LLC grew its position in shares of Ventas by 1,135.1% in the 3rd quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock worth $108,686,000 after acquiring an additional 1,427,151 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on VTR shares. Royal Bank Of Canada upped their price target on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research report on Tuesday, February 10th. Morgan Stanley set a $90.00 price objective on shares of Ventas in a report on Friday, February 13th. Citigroup boosted their target price on shares of Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. UBS Group reissued a “neutral” rating and set a $85.00 target price on shares of Ventas in a report on Monday, February 9th. Finally, Argus set a $88.00 price target on shares of Ventas in a research report on Tuesday, February 10th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.00.

Check Out Our Latest Research Report on VTR

Insider Activity

In related news, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president owned 72,755 shares in the company, valued at $6,184,175. This represents a 32.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the transaction, the chief financial officer owned 138,434 shares of the company’s stock, valued at $10,694,026.50. This represents a 17.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 86,106 shares of company stock valued at $6,931,397. Company insiders own 0.80% of the company’s stock.

Ventas Stock Performance

Shares of NYSE VTR opened at $86.68 on Friday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03. The stock has a 50 day simple moving average of $81.46 and a 200-day simple moving average of $76.33. The company has a market cap of $41.17 billion, a PE ratio of 160.52, a P/E/G ratio of 2.10 and a beta of 0.73. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $87.87.

Ventas (NYSE:VTRGet Free Report) last posted its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The firm’s revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, equities research analysts forecast that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. This is a positive change from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s dividend payout ratio is 355.56%.

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Featured Articles

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.